Completed
Dolutegravir Renal Impairment Study
NCT01353716
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States